C-MER Medical Holdings Limited (HKG:3309)
Hong Kong · Delayed Price · Currency is HKD 0.8950
+0.0100 (1.13%)
Aug 12, 2026, 3:53 PM HKT
C-MER Medical Holdings Financials Overview
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,947 | 1,947 | 1,913 | 1,924 | 1,732 | 1,113 |
Revenue Growth | 0.61% | 1.75% | -0.56% | 11.09% | 55.67% | 59.04% |
Gross Profit Gross Profit Growth | 603.67 | 603.67 | 596.9 | 618.96 | 447.7 | 358.23 |
Operating Income Operating Income Growth | 142.6 | 142.6 | 128.89 | 124.51 | 4.22 | 8.25 |
Net Income Net Income Growth | 100.37 | 100.37 | -135.16 | 62 | -21.88 | 21.86 |
Earnings Per Share EPS Growth | 0.08 | 0.08 | -0.11 | 0.05 | -0.02 | 0.02 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Mainland China Ophthalmic Business Mainland China Ophthalmic Business Growth | 520.33 | 520.33 | 546.99 | 587.71 | 502.94 | 568.67 |
Mainland China Other Business Mainland China Other Business Growth | 17.83 | 17.83 | - | - | - | - |
HK Medical Business HK Medical Business Growth | 948.73 | 948.73 | 901.59 | 932.09 | 805.66 | 543.91 |
Mainland China Dental Business Mainland China Dental Business Growth | 459.83 | 459.83 | 464.58 | 384.73 | 124.96 | - |
Total Total Growth | 1,947 | 1,947 | 1,913 | 1,924 | 1,732 | 1,113 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 465.96 | 465.96 | 467.25 | 557.42 | 698.51 | 442.36 |
Total Debt Total Debt Growth | 426.78 | 426.78 | 437.79 | 362.99 | 452.49 | 471.69 |
Net Cash (Debt) Net Cash Growth | 39.18 | 39.18 | 29.46 | 194.43 | 246.03 | -29.33 |
Net Cash Growth | 211.40% | 33.01% | -84.85% | -20.97% | - | - |
Net Cash Per Share Net Cash Per Share Growth | 0.03 | 0.03 | 0.02 | 0.15 | 0.20 | -0.03 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 283.29 | 283.29 | 283.12 | 361.15 | 164.86 | 144.4 |
Capital Expenditures CapEx Growth | -77.52 | -77.52 | -158.62 | -115.49 | -89.01 | -118.14 |
Free Cash Flow Free Cash Flow Growth | 205.77 | 205.77 | 124.51 | 245.67 | 75.86 | 26.26 |
Free Cash Flow Growth | 50.40% | 65.27% | -49.32% | 223.85% | 188.91% | -66.38% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 31.01% | 31.01% | 31.20% | 32.17% | 25.85% | 32.20% |
Operating Margin | 7.32% | 7.32% | 6.74% | 6.47% | 0.24% | 0.74% |
Pretax Margin | 7.99% | 7.99% | -3.98% | 6.46% | -0.65% | 2.42% |
Profit Margin | 5.16% | 5.16% | -7.07% | 3.22% | -1.26% | 1.97% |
FCF Margin | 10.57% | 10.57% | 6.51% | 12.77% | 4.38% | 2.36% |
| Fiscal Year | Current | FY 2025 | FY 2024 |
|---|---|---|---|
| Period Ending | Aug '26 Aug 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 |
Dividend Per Share Dividend Per Share Growth | 0.020 | 0.020 | 0.020 |
Dividend Per Share Growth | 50.00% | 0% | - |
Dividend Yield | 2.25% | 1.20% | 1.04% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 10.63 | 20.39 | - | 69.27 | - | 362.56 |
Forward PE | - | 31.78 | 31.78 | 41.70 | 49.00 | 34.42 |
P/FCF Ratio | 5.11 | 9.95 | 19.71 | 17.48 | 81.81 | 301.86 |
PS Ratio | 0.54 | 1.05 | 1.28 | 2.23 | 3.58 | 7.12 |